[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Chinook Therapeutics Inc (KDNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2017	12-2016	09-2016	06-2016	03-2016
Assets
Current Assets
Cash & Cash Equivalents	107,068	74,932	97,983	105,938	120,133
Marketable Securities	246,893	272,500	271,985	287,415	281,848
Receivables	1,048	1,138	1,056	1,384	1,867
TOTAL	$360,920	$354,764	$378,223	$407,815	$413,571

Non-Current Assets
PPE Net	26,443	26,384	25,931	17,227	5,548
Investments And Advances	1,992	14,474	17,179	3,566	6,479
Intangibles	35,914	35,485	37,969	38,231	39,237
Other Non-Current Assets	10,225	7,504	7,684	3,215	3,177
TOTAL	$74,574	$83,847	$88,763	$62,239	$54,441

Total Assets	$435,494	$438,611	$466,986	$470,054	$468,012

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,564	2,206	1,908	2,398	5,226
Accrued Expenses	11,274	13,374	16,961	22,337	20,821
TOTAL	$28,821	$30,632	$34,033	$39,906	$41,093

Non-Current Liabilities
Deferred Revenues	14,983	15,052	15,164	15,171	15,046
Other Non-Current Liabilities	5,204	5,141	3,542	3,508	3,594
TOTAL	$177,656	$180,759	$183,014	$184,209	$186,642

Total Liabilities	$206,477	$211,391	$217,047	$224,115	$227,735

Shareholders' Equity
Shares Outstanding, K	13,983	13,600	13,436	12,951	12,922
Common Shares	7	7	7	6	6
Retained earnings	-213,812	-192,000	-162,434	-127,383	-129,679
Other shareholders' equity	-1,343	-1,684	850	392	941
TOTAL	$229,017	$227,220	$249,939	$245,939	$240,277

Total Liabilities And Equity	$435,494	$438,611	$466,986	$470,054	$468,012